Published in J Infect Dis on June 18, 2014
The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci Rep (2015) 1.17
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol (2015) 1.07
Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. J Infect Dis (2015) 0.91
Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep (2015) 0.84
Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. Epidemiol Infect (2015) 0.83
Evaluation of Lysis Methods for the Extraction of Bacterial DNA for Analysis of the Vaginal Microbiota. PLoS One (2016) 0.79
Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses. Cancer Prev Res (Phila) (2016) 0.79
Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium. BMC Public Health (2016) 0.78
Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res (2016) 0.78
Optimizing methods and dodging pitfalls in microbiome research. Microbiome (2017) 0.77
Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunol (2017) 0.77
Recent advances in understanding and preventing human papillomavirus-related disease. F1000Res (2017) 0.75
The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome (2016) 0.75
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome (2017) 0.75
The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women. J Infect Dis (2016) 0.75
Mechanistic mathematical models: An underused platform for HPV research. Papillomavirus Res (2017) 0.75
Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection. Eur J Clin Microbiol Infect Dis (2017) 0.75
Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med (2005) 11.23
The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog (2008) 5.28
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer (2007) 3.99
The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis (2007) 3.93
HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA (2000) 3.93
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA (2001) 3.07
Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr (2003) 2.87
A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis (2004) 2.70
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One (2010) 2.62
Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis (2007) 2.42
Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod (2001) 2.26
Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol (2000) 2.25
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev (2001) 2.12
Multiple comparisons, explained. Am J Epidemiol (1998) 2.06
Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol (2003) 2.06
Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis (2005) 2.04
Comparison of self-collected and physician-collected vaginal swabs for microbiome analysis. J Clin Microbiol (2010) 1.82
Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis (2005) 1.72
Defense factors of vaginal lactobacilli. Am J Obstet Gynecol (2001) 1.68
Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect (2000) 1.64
In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis (2011) 1.56
Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect Dis (2011) 1.45
The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol (2008) 1.37
The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora. Sex Transm Dis (1997) 1.37
Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.34
At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci U S A (2010) 1.30
Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol (1993) 1.28
Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis (2007) 1.28
Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl Environ Microbiol (1999) 1.28
Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One (2013) 1.13
The microbiota of the vagina and its influence on women's health and disease. Am J Med Sci (2012) 1.11
Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infect Dis (2010) 1.09
A general goodness-of-fit test for Markov and hidden Markov models. Stat Med (2008) 1.06
Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces (2011) 1.00
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J Infect Dis (2012) 1.00
Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol Oncol (1992) 0.96
Biosurfactants produced by Lactobacillus. Methods Enzymol (1999) 0.93
Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol (2011) 0.93
Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study. BMC Infect Dis (2013) 0.92
A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis (2012) 0.90
Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. J Med Microbiol (2013) 0.90
Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. J Infect Dis (2011) 0.87
Bacterial vaginosis is conducive to the persistence of HPV infection. Int J STD AIDS (2012) 0.85
Characterizing the temporal dynamics of human papillomavirus DNA detectability using short-interval sampling. Cancer Epidemiol Biomarkers Prev (2013) 0.84
Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol. J Infect Dis (2004) 0.81
Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study. Eur J Cancer Prev (2013) 0.81
The association of current hormonal contraceptive use with type-specific HPV detection. Sex Transm Infect (2011) 0.79